choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Stelara

Stelara Newsletter
  • Can HR help limit the rising cost of psoriasis treatment? 22 Apr 2025 22:48 GMT

    … medication use trends in the U.S., utilization of psoriasis drugs … cost of psoriasis treatment drugs like Stelara and Tremfya exceeding … pharmaceutical landscape for moderate-to-severe eczema treatment. … newer treatments, like bimekizumab—approved by the FDA …

  • 7 Best Pharmaceutical Stocks to Buy for Income 21 Apr 2025 22:16 GMT

    … leader in the pharmaceutical, medical device and consumer … include anti-inflammation drug Stelara, multiple myeloma and … trials for new formulations of its blockbuster GLP-1 treatment … largest biotechnology companies. Its leading commercial drugs include …

  • President Trump Signs Executive Order to Bring Down Drug Prices 17 Apr 2025 01:49 GMT

    … treatment of small molecule drugs with biologics in the Medicare Drug … decade closes out (Stelara, ustekinumab; Enbrel, etanercept … years, with clinical trials accounting for more … ; the Medicare Drug Price Negotiation Program. National Pharmaceutical Council. …

  • Psoriasis Drug Costs Have Risen, but Less Expensive Options Are Out There 17 Apr 2025 03:15 GMT

    … and doctors chose lower-cost treatment options or if drug prices … medications have been approved by the FDA to treat it. These drugs … other hand, drugs such as Humira (adalimumab) and Stelara (ustekinumab) may … /IL-23 inhibitor Stelara; and a few IL- …

  • How U.S. Medicare Prices Compare to Other Rich Nations 16 Apr 2025 17:07 GMT

    … pharmaceutical companies for 10 high-expenditure drugs that lack generic competition. The Medicare … (Johnson & Johnson) 🇺🇸 Pharmacyclics (AbbVie) Stelara 🇺🇸 Janssen (Johnson & Johnson) Enbrel 🇺🇸 …

  • Medicare Part D Updates for 2025 and Beyond 15 Apr 2025 17:10 GMT

    … in managing Medicare-eligible patients. For the optimal delivery of pharmaceutical care … treatments, antidepressants, antipsychotics, anticonvulsants, immunosuppressants, and anticancer agents.11 Additionally, the Medicare Prescription Drug …

  • J&J earnings beat estimates on strong cancer drug sales 15 Apr 2025 11:59 GMT

    … rout earlier this month as pharmaceuticals were exempted from the first … half of the year. Innovative medicine revenue was buttressed by a … . Sales of the drugmaker’s blockbuster psoriasis treatment Stelara fell more than 33% …

  • J&J beats quarterly sales and profit estimates on cancer drug sales 15 Apr 2025 10:33 GMT

    … half of the year. Innovative medicine revenue was buttressed by a … makes in partnership with Legend Biotech, brought in sales of $369 … . Sales of the drugmaker';s blockbuster psoriasis treatment Stelara fell more than 33% …

  • J&J Beats Q1 Analyst Estimates Thanks To Tremfya, Carvykti, While Stelara Fades 15 Apr 2025 13:50 GMT

    … share of $4.54. The medicines unit provided $13.9 billion … ;J’s fading immunology star Stelara, meanwhile, suffered a setback in … changes to the Medicare’s Part D policies. The drug pulled in … Phase III head-to-head trial that read out in March …

  • Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit 15 Apr 2025 13:28 GMT

    … of $2.60. The pharmaceutical giant reported sales of $21 … was 3.3%. Innovative Medicine sales increased 2.3% or … Positive Results For Psoriasis Oral Pill Study Growth was driven … (810) basis points impact from Stelara (ustekinumab) in immunology. Cancer …

Satisfied with the content?

Continue to create your account.